Concepedia

Amir I. Tukhvatulin

AI

Statistics

Publications

32

Citations

4.1K

H-Index

20

Active since

2010

Affiliations

Gamalei Institute of Epidemiology and Microbiology(Current)

Ministry of Health of the Russian Federation

Sechenov University

Russian Academy of Sciences

Roswell Park Comprehensive Cancer Center

Amir I. Tukhvatulin is an author at Gamalei Institute of Epidemiology and Microbiology specializing in immunology, infectious diseases, and vaccinology.

ORCID

Publications per year

2010–2023

32

Publications

32

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Denis Y. Logunov, Inna V. Dolzhikova, Dmitry V. Shcheblyakov et al. · The Lancet · 2021 · 1.8K citations · Full text

, , +16

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

Denis Y. Logunov, Inna V. Dolzhikova, Olga V. Zubkova et al. · The Lancet · 2020 · 1.1K citations · Full text

, , +14

Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia

Inna V. Dolzhikova, Olga V. Zubkova, Amir I. Tukhvatulin et al. · Human Vaccines & Immunotherapeutics · 2017 · 133 citations · Full text

, , +17

Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants

Vladimir А. Gushchin, Inna V. Dolzhikova, Andrei E. Siniavin et al. · Vaccines · 2021 · 119 citations · Full text

, , +14

Receptor Mincle promotes skin allergies and is capable of recognizing cholesterol sulfate

Alexey V. Kostarnoy, Petya G. Gancheva, Bernd Lepenies et al. · Proceedings of the National Academy of Sciences · 2017 · 91 citations · Full text

, , +14

1–5 of 32